Table 1.
Variables | Cases | SMYD2 expression | P value | |
---|---|---|---|---|
(n=107) | Low (n=65) | High (n=42) | ||
Age (years) | 0.083 | |||
≤40 years | 50 | 26 | 24 | |
>40 years | 57 | 39 | 18 | |
Gender | 0.396 | |||
Female | 82 | 48 | 34 | |
Male | 25 | 17 | 8 | |
Tumor size | <0.001* | |||
≤2.0 cm | 68 | 50 | 18 | |
>2.0 cm | 39 | 15 | 24 | |
TCI | 0.654 | |||
Negative | 69 | 43 | 26 | |
Positive | 38 | 22 | 16 | |
ETE | 0.576 | |||
Negative | 55 | 32 | 23 | |
Positive | 52 | 33 | 19 | |
LN metastasis | 0.003* | |||
Negative | 74 | 52 | 22 | |
Positive | 33 | 13 | 20 | |
TNM stage | 0.004* | |||
I–II | 84 | 57 | 27 | |
III–IV | 23 | 8 | 15 |
P<0.05 was considered as statistically significant.
ETE – extrathyroidal extension; LN – lymph node; TCI – thyroid capsular invasion; SMYD2 – SET and MYND domain-containing protein 2.